1-3 of 3
Simon Cronin, Pharm, D
Close
Sort by
Journal Articles

Successful Hematopoietic Stem Cells (HSC) Mobilization in Patients Who Fail Plerixafor Mobilization for Autologous Stem Cells Transplant (ASCT)

Tania Jain, MD, Muthu Veeraputhiran, MD, Simon Cronin, Pharm, D, Zaid Al-Kadhimi, MD, Muneer H. Abidi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Lawrence G Lum, MD, DSc, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2012) 120 (21): 1913.
https://doi.org/10.1182/blood.V120.21.1913.1913
Published: 2012
Journal Articles

Cytoprotective Palifermin Allowed Melphalan Dose Escalation to 280mg/ 2 for Multiple Myeloma Patients with Normal Renal Function Receiving Autologous Stem Cell Transplantation (ASCT) - Final Results of a Phase 1 Trial

Muneer H. Abidi, MD, Nishant Tageja, MD, Lawrence G. Lum, MD, DSC, Judith Abrams, Zaid Al-Kadhimi, Lois Ayash, Simon Cronin, Pharm, D, Marie Ventimiglia, Abhinav Deol, MBBS, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2401.
https://doi.org/10.1182/blood.V116.21.2401.2401
Published: 2010
Journal Articles

A Phase I Study of Bortezomib During Maintenance Phase After High-Dose Melphalan and Autologous Stem Cell Transplantation In Patients with Multiple Myeloma

Muneer H. Abidi, MD, Zartash Gul, MD, Lawrence G. Lum, MD, DSC, Judith Abrams, Simon Cronin, Pharm, D, Marie Ventimiglia, Abhinav Deol, MBBS, MD, Lois Ayash, Zaid Al-Kadhimi, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2387.
https://doi.org/10.1182/blood.V116.21.2387.2387
Published: 2010